Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of HP-3150 (diclofenac patch) in patients with cancer pain
jRCT2080223595Phase 3Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in cancer pain (3 arms), sponsored by Hisamitsu Pharmaceutical Co., Inc. Started Jul 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080223595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223595.